BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Burgess CR, Scammell TE. Narcolepsy: neural mechanisms of sleepiness and cataplexy. J Neurosci 2012;32:12305-11. [PMID: 22956821 DOI: 10.1523/JNEUROSCI.2630-12.2012] [Cited by in Crossref: 82] [Cited by in F6Publishing: 35] [Article Influence: 8.2] [Reference Citation Analysis]
Number Citing Articles
1 Çak HT, Haliloğlu G, Düzgün G, Yüce A, Topçu M. Successful treatment of cataplexy in patients with early-infantile Niemann–Pick disease type C: Use of tricyclic antidepressants. European Journal of Paediatric Neurology 2014;18:811-5. [DOI: 10.1016/j.ejpn.2014.07.009] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
2 Bandaru SS, Khanday MA, Ibrahim N, Naganuma F, Vetrivelan R. Sleep-Wake Control by Melanin-Concentrating Hormone (MCH) Neurons: a Review of Recent Findings. Curr Neurol Neurosci Rep 2020;20:55. [PMID: 33006677 DOI: 10.1007/s11910-020-01075-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
3 Holm A, Bang-Berthelsen CH, Knudsen S, Kornum BR, Modvig S, Jennum P, Gammeltoft S. miRNA profiles in plasma from patients with sleep disorders reveal dysregulation of miRNAs in narcolepsy and other central hypersomnias. Sleep 2014;37:1525-33. [PMID: 25142559 DOI: 10.5665/sleep.4004] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 2.6] [Reference Citation Analysis]
4 Lai JB, Han MM, Xu Y, Hu SH. Effective treatment of narcolepsy-like symptoms with high-frequency repetitive transcranial magnetic stimulation: A case report. Medicine (Baltimore) 2017;96:e8645. [PMID: 29145290 DOI: 10.1097/MD.0000000000008645] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 1.2] [Reference Citation Analysis]
5 Naganuma F, Bandaru SS, Absi G, Mahoney CE, Scammell TE, Vetrivelan R. Melanin-concentrating hormone neurons contribute to dysregulation of rapid eye movement sleep in narcolepsy. Neurobiol Dis 2018;120:12-20. [PMID: 30149182 DOI: 10.1016/j.nbd.2018.08.012] [Cited by in Crossref: 18] [Cited by in F6Publishing: 13] [Article Influence: 4.5] [Reference Citation Analysis]
6 Mahlios J, De la Herrán-Arita AK, Mignot E. The autoimmune basis of narcolepsy. Curr Opin Neurobiol 2013;23:767-73. [PMID: 23725858 DOI: 10.1016/j.conb.2013.04.013] [Cited by in Crossref: 110] [Cited by in F6Publishing: 84] [Article Influence: 12.2] [Reference Citation Analysis]
7 Wheeler DS, Wan S, Miller A, Angeli N, Adileh B, Hu W, Holland PC. Role of lateral hypothalamus in two aspects of attention in associative learning. Eur J Neurosci 2014;40:2359-77. [PMID: 24750426 DOI: 10.1111/ejn.12592] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 2.0] [Reference Citation Analysis]
8 Oishi Y, Williams RH, Agostinelli L, Arrigoni E, Fuller PM, Mochizuki T, Saper CB, Scammell TE. Role of the medial prefrontal cortex in cataplexy. J Neurosci 2013;33:9743-51. [PMID: 23739971 DOI: 10.1523/JNEUROSCI.0499-13.2013] [Cited by in Crossref: 56] [Cited by in F6Publishing: 37] [Article Influence: 6.2] [Reference Citation Analysis]
9 Nevárez N, de Lecea L. Recent advances in understanding the roles of hypocretin/orexin in arousal, affect, and motivation. F1000Res 2018;7:F1000 Faculty Rev-1421. [PMID: 30254737 DOI: 10.12688/f1000research.15097.1] [Cited by in Crossref: 23] [Cited by in F6Publishing: 18] [Article Influence: 5.8] [Reference Citation Analysis]
10 De la Herrán-Arita AK, García-García F. Narcolepsy as an immune-mediated disease. Sleep Disord 2014;2014:792687. [PMID: 24551456 DOI: 10.1155/2014/792687] [Cited by in Crossref: 22] [Cited by in F6Publishing: 17] [Article Influence: 2.8] [Reference Citation Analysis]
11 Kuhn A, Brodbeck V, Tagliazucchi E, Morzelewski A, von Wegner F, Laufs H. Narcoleptic Patients Show Fragmented EEG-Microstructure During Early NREM Sleep. Brain Topogr 2015;28:619-35. [PMID: 25168255 DOI: 10.1007/s10548-014-0387-1] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 2.3] [Reference Citation Analysis]
12 Larson-Prior LJ, Ju YE, Galvin JE. Cortical-subcortical interactions in hypersomnia disorders: mechanisms underlying cognitive and behavioral aspects of the sleep-wake cycle. Front Neurol 2014;5:165. [PMID: 25309500 DOI: 10.3389/fneur.2014.00165] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
13 Shah S, Ren A, Fan D, Zhang Z, Zhao N, Yang X, Luo M, Wang W, Hu F, Rehman M, Badarneh O, Abbasi Q. Internet of Things for Sensing: A Case Study in the Healthcare System. Applied Sciences 2018;8:508. [DOI: 10.3390/app8040508] [Cited by in Crossref: 31] [Article Influence: 7.8] [Reference Citation Analysis]
14 Fulcher BD, Phillips AJ, Postnova S, Robinson PA. A physiologically based model of orexinergic stabilization of sleep and wake. PLoS One 2014;9:e91982. [PMID: 24651580 DOI: 10.1371/journal.pone.0091982] [Cited by in Crossref: 33] [Cited by in F6Publishing: 24] [Article Influence: 4.1] [Reference Citation Analysis]
15 Branch AF, Navidi W, Tabuchi S, Terao A, Yamanaka A, Scammell TE, Diniz Behn C. Progressive Loss of the Orexin Neurons Reveals Dual Effects on Wakefulness. Sleep 2016;39:369-77. [PMID: 26446125 DOI: 10.5665/sleep.5446] [Cited by in Crossref: 30] [Cited by in F6Publishing: 27] [Article Influence: 5.0] [Reference Citation Analysis]
16 Calva CB, Fayyaz H, Fadel JR. Effects of Intranasal Orexin-A (Hypocretin-1) Administration on Neuronal Activation, Neurochemistry, and Attention in Aged Rats. Front Aging Neurosci 2019;11:362. [PMID: 32038222 DOI: 10.3389/fnagi.2019.00362] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
17 Smith CM, Walker AW, Hosken IT, Chua BE, Zhang C, Haidar M, Gundlach AL. Relaxin-3/RXFP3 networks: an emerging target for the treatment of depression and other neuropsychiatric diseases? Front Pharmacol 2014;5:46. [PMID: 24711793 DOI: 10.3389/fphar.2014.00046] [Cited by in Crossref: 35] [Cited by in F6Publishing: 34] [Article Influence: 4.4] [Reference Citation Analysis]
18 Black SW, Schwartz MD, Chen TM, Hoener MC, Kilduff TS. Trace Amine-Associated Receptor 1 Agonists as Narcolepsy Therapeutics. Biol Psychiatry 2017;82:623-33. [PMID: 27919403 DOI: 10.1016/j.biopsych.2016.10.012] [Cited by in Crossref: 28] [Cited by in F6Publishing: 26] [Article Influence: 4.7] [Reference Citation Analysis]
19 Montplaisir J, Petit D, Quinn MJ, Ouakki M, Deceuninck G, Desautels A, Mignot E, De Wals P. Risk of narcolepsy associated with inactivated adjuvanted (AS03) A/H1N1 (2009) pandemic influenza vaccine in Quebec. PLoS One 2014;9:e108489. [PMID: 25264897 DOI: 10.1371/journal.pone.0108489] [Cited by in Crossref: 64] [Cited by in F6Publishing: 53] [Article Influence: 8.0] [Reference Citation Analysis]
20 Bonnavion P, Mickelsen LE, Fujita A, de Lecea L, Jackson AC. Hubs and spokes of the lateral hypothalamus: cell types, circuits and behaviour. J Physiol 2016;594:6443-62. [PMID: 27302606 DOI: 10.1113/JP271946] [Cited by in Crossref: 95] [Cited by in F6Publishing: 53] [Article Influence: 15.8] [Reference Citation Analysis]
21 Nirogi R, Benade V, Daripelli S, Subramanian R, Kamuju V, Bhyrapuneni G, Muddana NR, Mekala VR, Petlu S, Jayarajan P, Badange R, Shinde A, Jasti V. Samelisant (SUVN-G3031), a potent, selective and orally active histamine H3 receptor inverse agonist for the potential treatment of narcolepsy: pharmacological and neurochemical characterisation. Psychopharmacology (Berl) 2021;238:1495-511. [PMID: 33550481 DOI: 10.1007/s00213-021-05779-x] [Reference Citation Analysis]
22 Tesoriero C, Codita A, Zhang MD, Cherninsky A, Karlsson H, Grassi-Zucconi G, Bertini G, Harkany T, Ljungberg K, Liljeström P, Hökfelt TG, Bentivoglio M, Kristensson K. H1N1 influenza virus induces narcolepsy-like sleep disruption and targets sleep-wake regulatory neurons in mice. Proc Natl Acad Sci U S A 2016;113:E368-77. [PMID: 26668381 DOI: 10.1073/pnas.1521463112] [Cited by in Crossref: 52] [Cited by in F6Publishing: 40] [Article Influence: 7.4] [Reference Citation Analysis]
23 Adamantidis AR, Schmidt MH, Carter ME, Burdakov D, Peyron C, Scammell TE. A circuit perspective on narcolepsy. Sleep 2020;43:zsz296. [PMID: 31919524 DOI: 10.1093/sleep/zsz296] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 8.0] [Reference Citation Analysis]
24 Meletti S, Vaudano AE, Pizza F, Ruggieri A, Vandi S, Teggi A, Franceschini C, Benuzzi F, Nichelli PF, Plazzi G. The Brain Correlates of Laugh and Cataplexy in Childhood Narcolepsy. J Neurosci 2015;35:11583-94. [PMID: 26290235 DOI: 10.1523/JNEUROSCI.0840-15.2015] [Cited by in Crossref: 41] [Cited by in F6Publishing: 15] [Article Influence: 5.9] [Reference Citation Analysis]
25 Arrigoni E, Chen MC, Fuller PM. The anatomical, cellular and synaptic basis of motor atonia during rapid eye movement sleep. J Physiol 2016;594:5391-414. [PMID: 27060683 DOI: 10.1113/JP271324] [Cited by in Crossref: 32] [Cited by in F6Publishing: 10] [Article Influence: 5.3] [Reference Citation Analysis]
26 Meskill GJ, Kallweit U, Zarycranski D, Caussé C, Finance O, Ligneau X, Davis CW. Pitolisant for the treatment of cataplexy in adults with narcolepsy. Expert Opinion on Orphan Drugs. [DOI: 10.1080/21678707.2021.2022472] [Reference Citation Analysis]
27 Elliott JE, De Luche SE, Churchill MJ, Moore C, Cohen AS, Meshul CK, Lim MM. Dietary therapy restores glutamatergic input to orexin/hypocretin neurons after traumatic brain injury in mice. Sleep 2018;41. [PMID: 29315422 DOI: 10.1093/sleep/zsx212] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
28 Kumar S, Sagili H. Etiopathogenesis and neurobiology of narcolepsy: a review. J Clin Diagn Res 2014;8:190-5. [PMID: 24701532 DOI: 10.7860/JCDR/2014/7295.4057] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
29 van den Pol AN. Neuropeptide transmission in brain circuits. Neuron 2012;76:98-115. [PMID: 23040809 DOI: 10.1016/j.neuron.2012.09.014] [Cited by in Crossref: 350] [Cited by in F6Publishing: 332] [Article Influence: 35.0] [Reference Citation Analysis]
30 Hung CJ, Ono D, Kilduff TS, Yamanaka A. Dual orexin and MCH neuron-ablated mice display severe sleep attacks and cataplexy. Elife 2020;9:e54275. [PMID: 32314734 DOI: 10.7554/eLife.54275] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
31 Pillen S, Pizza F, Dhondt K, Scammell TE, Overeem S. Cataplexy and Its Mimics: Clinical Recognition and Management. Curr Treat Options Neurol 2017;19:23. [PMID: 28478511 DOI: 10.1007/s11940-017-0459-0] [Cited by in Crossref: 23] [Cited by in F6Publishing: 16] [Article Influence: 4.6] [Reference Citation Analysis]
32 Burgess CR, Oishi Y, Mochizuki T, Peever JH, Scammell TE. Amygdala lesions reduce cataplexy in orexin knock-out mice. J Neurosci 2013;33:9734-42. [PMID: 23739970 DOI: 10.1523/JNEUROSCI.5632-12.2013] [Cited by in Crossref: 63] [Cited by in F6Publishing: 36] [Article Influence: 7.0] [Reference Citation Analysis]
33 Swick TJ. Treatment paradigms for cataplexy in narcolepsy: past, present, and future. Nat Sci Sleep 2015;7:159-69. [PMID: 26715865 DOI: 10.2147/NSS.S92140] [Cited by in Crossref: 4] [Cited by in F6Publishing: 8] [Article Influence: 0.6] [Reference Citation Analysis]
34 Shiromani PJ, Blanco-Centurion C, Vidal-Ortiz A. Mapping Network Activity in Sleep. Front Neurosci 2021;15:646468. [PMID: 33828453 DOI: 10.3389/fnins.2021.646468] [Reference Citation Analysis]
35 Seong MJ, Hong SB. Autoimmunity and Immunotherapy in Narcolepsy. Sleep Med Res 2017;8:1-7. [DOI: 10.17241/smr.2017.00052] [Cited by in Crossref: 3] [Article Influence: 0.6] [Reference Citation Analysis]
36 Arias-Carrión O, Murillo-Rodríguez E. Effects of hypocretin/orexin cell transplantation on narcoleptic-like sleep behavior in rats. PLoS One 2014;9:e95342. [PMID: 24736646 DOI: 10.1371/journal.pone.0095342] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 2.6] [Reference Citation Analysis]
37 Mahoney CE, Agostinelli LJ, Brooks JN, Lowell BB, Scammell TE. GABAergic Neurons of the Central Amygdala Promote Cataplexy. J Neurosci 2017;37:3995-4006. [PMID: 28235898 DOI: 10.1523/JNEUROSCI.4065-15.2017] [Cited by in Crossref: 30] [Cited by in F6Publishing: 17] [Article Influence: 6.0] [Reference Citation Analysis]
38 Black SW, Yamanaka A, Kilduff TS. Challenges in the development of therapeutics for narcolepsy. Prog Neurobiol 2017;152:89-113. [PMID: 26721620 DOI: 10.1016/j.pneurobio.2015.12.002] [Cited by in Crossref: 32] [Cited by in F6Publishing: 27] [Article Influence: 4.6] [Reference Citation Analysis]
39 Black SW, Morairty SR, Chen TM, Leung AK, Wisor JP, Yamanaka A, Kilduff TS. GABAB agonism promotes sleep and reduces cataplexy in murine narcolepsy. J Neurosci 2014;34:6485-94. [PMID: 24806675 DOI: 10.1523/JNEUROSCI.0080-14.2014] [Cited by in Crossref: 32] [Cited by in F6Publishing: 19] [Article Influence: 4.0] [Reference Citation Analysis]
40 George WT, Varghese R, Khawaja IS. New Onset of Compulsive Gambling Associated With Modafinil: A Case Report. Prim Care Companion CNS Disord 2015;17. [PMID: 26137352 DOI: 10.4088/PCC.14l01707] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
41 Yelin-Bekerman L, Elbaz I, Diber A, Dahary D, Gibbs-Bar L, Alon S, Lerer-Goldshtein T, Appelbaum L. Hypocretin neuron-specific transcriptome profiling identifies the sleep modulator Kcnh4a. Elife 2015;4:e08638. [PMID: 26426478 DOI: 10.7554/eLife.08638] [Cited by in Crossref: 42] [Cited by in F6Publishing: 26] [Article Influence: 6.0] [Reference Citation Analysis]